Literature DB >> 455289

Effects of 2'-deoxycoformycin infusion on mouse adenosine deaminase.

A Tedde, M E Balis, R Schonberg, P P Trotta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455289

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

Review 2.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats.

Authors:  M E Stromski; A van Waarde; M J Avison; G Thulin; K M Gaudio; M Kashgarian; R G Shulman; N J Siegel
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

5.  Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.

Authors:  H Ratech; R Hirschhorn; G J Thorbecke
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

6.  Animal model for immune dysfunction associated with adenosine deaminase deficiency.

Authors:  A Tedde; M E Balis; S Ikehara; R Pahwa; R A Good; P P Trotta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  Genetic variability of purine nucleoside phosphorylase activity in the mouse: relationship to Np-1 and Np-2.

Authors:  F F Snyder; F G Biddle; T Lukey; M J Sparling
Journal:  Biochem Genet       Date:  1983-04       Impact factor: 1.890

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.